483 Roundup: FDA Targets Eight Device Facilities

The GMP Letter
The FDA cited eight device firms for a range of compliance issues including inadequate complaint procedures, lack of written quality procedures, shipping products prior to approval, inadequate documentation, and unreported software changes.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $157.00